We found that 10/14 ACCs either expressed the MYB-NFIB fusion gene and/or had rearrangements of MYB.     ///    "MYB-NFIB is a useful biomarker for ACC and MYB, and its downstream target genes may be potential therapeutic targets for these tumours.. "